379 related articles for article (PubMed ID: 25283500)
1. Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer.
White ID; Wilson J; Aslet P; Baxter AB; Birtle A; Challacombe B; Coe J; Grover L; Payne H; Russell S; Sangar V; Van As N; Kirby M
Int J Clin Pract; 2015 Jan; 69(1):106-23. PubMed ID: 25283500
[TBL] [Abstract][Full Text] [Related]
2. Development of UK recommendations on treatment for post-surgical erectile dysfunction.
Kirby MG; White ID; Butcher J; Challacombe B; Coe J; Grover L; Hegarty P; Jackson G; Lowndes A; Payne H; Rees J; Sangar V; Thompson A
Int J Clin Pract; 2014 May; 68(5):590-608. PubMed ID: 24188207
[TBL] [Abstract][Full Text] [Related]
3. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer.
DiBlasio CJ; Malcolm JB; Derweesh IH; Womack JH; Kincade MC; Mancini JG; Ogles ML; Lamar KD; Patterson AL; Wake RW
BJU Int; 2008 Jul; 102(1):39-43. PubMed ID: 18294309
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of androgen deprivation therapy in prostate cancer patients.
Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
[TBL] [Abstract][Full Text] [Related]
5. [An active sex life is possible for men undergoing androgen deprivation therapy for prostate cancer].
Fode M; Østergren P; Jensen CF; Azawi N; Frey A; Sønksen J
Ugeskr Laeger; 2015 Jun; 177(24):. PubMed ID: 26058525
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review of the Role of Penile Rehabilitation in Prostate Cancer Patients Receiving Radiotherapy and Androgen Deprivation Therapy.
Doherty W; Bridge P
J Med Imaging Radiat Sci; 2019 Mar; 50(1):171-178. PubMed ID: 30777241
[TBL] [Abstract][Full Text] [Related]
7. Androgen deprivation therapy: evidence-based management of side effects.
Ahmadi H; Daneshmand S
BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
[TBL] [Abstract][Full Text] [Related]
8. Adverse effects of androgen deprivation therapy and strategies to mitigate them.
Nguyen PL; Alibhai SM; Basaria S; D'Amico AV; Kantoff PW; Keating NL; Penson DF; Rosario DJ; Tombal B; Smith MR
Eur Urol; 2015 May; 67(5):825-36. PubMed ID: 25097095
[TBL] [Abstract][Full Text] [Related]
9. Management of erectile dysfunction after prostate cancer treatment: cross-sectional surveys of the perceptions and experiences of patients and healthcare professionals in the UK.
Dyer A; Kirby M; White ID; Cooper AM
BMJ Open; 2019 Oct; 9(10):e030856. PubMed ID: 31585974
[TBL] [Abstract][Full Text] [Related]
10. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity.
Higano CS
Urology; 2003 Feb; 61(2 Suppl 1):32-8. PubMed ID: 12667885
[TBL] [Abstract][Full Text] [Related]
11. Challenges in Reporting the Effect of Radiotherapy on Erectile Function.
Nukala V; Incrocci L; Hunt AA; Ballas L; Koontz BF
J Sex Med; 2020 Jun; 17(6):1053-1059. PubMed ID: 32312661
[TBL] [Abstract][Full Text] [Related]
12. Androgen deprivation therapy before radical prostatectomy is associated with poorer postoperative erectile function outcomes.
Mazzola CR; Deveci S; Heck M; Mulhall JP
BJU Int; 2012 Jul; 110(1):112-6. PubMed ID: 22093870
[TBL] [Abstract][Full Text] [Related]
13. The unique needs of couples experiencing androgen deprivation therapy for prostate cancer.
Walker LM; Robinson JW
J Sex Marital Ther; 2010; 36(2):154-65. PubMed ID: 20169495
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy and short-term androgen deprivation for localized prostate cancer.
Jones CU; Hunt D; McGowan DG; Amin MB; Chetner MP; Bruner DW; Leibenhaut MH; Husain SM; Rotman M; Souhami L; Sandler HM; Shipley WU
N Engl J Med; 2011 Jul; 365(2):107-18. PubMed ID: 21751904
[TBL] [Abstract][Full Text] [Related]
15. Androgen deprivation therapy for prostate cancer: recommendations to improve patient and partner quality of life.
Elliott S; Latini DM; Walker LM; Wassersug R; Robinson JW;
J Sex Med; 2010 Sep; 7(9):2996-3010. PubMed ID: 20626600
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy.
Lee CE; Leslie WD; Lau YK
BMC Cancer; 2012 Mar; 12():103. PubMed ID: 22436542
[TBL] [Abstract][Full Text] [Related]
17. Androgen deprivation therapy impact on quality of life and cardiovascular health, monitoring therapeutic replacement.
Trost LW; Serefoglu E; Gokce A; Linder BJ; Sartor AO; Hellstrom WJ
J Sex Med; 2013 Feb; 10 Suppl 1():84-101. PubMed ID: 23387914
[TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation therapy for prostate cancer.
Sharifi N; Gulley JL; Dahut WL
JAMA; 2005 Jul; 294(2):238-44. PubMed ID: 16014598
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the impact of androgen deprivation therapy on sildenafil citrate response following radiation therapy for prostate cancer.
Teloken PE; Ohebshalom M; Mohideen N; Mulhall JP
J Urol; 2007 Dec; 178(6):2521-5. PubMed ID: 17937948
[TBL] [Abstract][Full Text] [Related]
20. Bone and metabolic health in patients with non-metastatic prostate cancer who are receiving androgen deprivation therapy.
Grossmann M; Hamilton EJ; Gilfillan C; Bolton D; Joon DL; Zajac JD
Med J Aust; 2011 Mar; 194(6):301-6. PubMed ID: 21426285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
